2.2. Application of Consolidated Mathematical Growth Model of Primary Tumor and Secondary Distant Metastases (CoMPaS) in Patients with ER/PR/HER2/Ki-67 Subtypes and Stage I/II/III Breast Cancer in Clinical Practices. This evidence concerns the gene PGR and breast carcinoma.